U.S. Markets closed

GenMark Diagnostics, Inc. (GNMK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.30+0.21 (+1.89%)
At close: 4:00PM EDT

11.20 -0.10 (-0.88%)
After hours: 4:15PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close11.09
Open11.07
Bid11.00 x 3000
Ask11.32 x 3200
Day's Range10.89 - 11.32
52 Week Range3.36 - 20.88
Volume561,630
Avg. Volume1,160,366
Market Cap803.106M
Beta (5Y Monthly)2.91
PE Ratio (TTM)N/A
EPS (TTM)-0.55
Earnings DateOct 28, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.60
  • GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks

    GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    GenMark Diagnostics (GNMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020

    CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, October 28, 2020. Management will hold a conference call to review the company's financial performance starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the GenMark Diagnostics, Inc. website at www.genmarkdx.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number 2955234 approximately ten minutes prior to the start time.ABOUT GENMARK DIAGNOSTICS GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.Investor Relations Contact Leigh Salvo (415) 937-5404 ir@genmarkdx.com

  • Dow Jones Today, Stocks Climb Toward October Surprise; Deal Chatter Ignites Xilinx
    Investor's Business Daily

    Dow Jones Today, Stocks Climb Toward October Surprise; Deal Chatter Ignites Xilinx

    Xilinx and NXP Semiconductors were early leaders, as stimulus speculation lifted stocks and the Dow Jones today toward a strong weekly finish.